Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 4 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 5 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

Progression of retinal, chronic kidney disease may be influenced by similar risk factors

15 Aug 2019

It is possible that similar mechanisms mediate the progression of both retinopathy and chronic kidney disease (CKD), with a recent study showing that the association between the two progression events found on initial analysis has disappeared after adjusting for known risk factors for both diseases.

Researchers looked at 1,936 patients with CKD enrolled in the multicentre, prospective Chronic Renal Insufficiency Cohort (CRIC) Study. Of these, 1,583 attended nonmydriatic fundus photography session at baseline, and 1,025 had follow-up photography taken after a mean of 3.5 years.

Among 1,025 participants who had baseline and follow-up photographs, 930 (90.7 percent) showed no retinopathy progression, 26 (2.5 percent) showed 2-step worsening, 32 (3.1 percent) showed 3-step worsening, and 37 (3.6 percent) showed more than 3-step worsening.

End-stage renal disease (ESRD) or 50-percent decrease in estimated glomerular filtration rate (eGFR) occurred in 88 of 930 participants who had no retinopathy progression and in 18 of 95 participants with retinopathy progression.

Univariable logistic regression analysis revealed that worsening of retinopathy, as opposed to stable retinopathy, was associated with a twofold likelihood of CKD progression (odds ratio [OR], 2.24, 95 percent CI, 1.28–3.91; p=0.005). This association disappeared upon further adjustments for known risk factors for both diseases (OR, 1.62, 0.77–3.39; p=0.20).

The fact that the association became negligible in multivariable regression models implies that progression of CKD and retinopathy may be influenced by similar risk factors, the researchers pointed out. Additionally, the findings suggest substantial prevalence and progression of retinopathy in participants with CKD, supporting vigilance for monitoring eye disease in patients with CKD.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 4 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 5 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.